Haemonetics (HAE) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $78.03 --0%
Revenue Growth %: +2.3%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Revenue Growth %: +2.3%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $346 million versus the consensus estimate of $337.04 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Esquire Financial Holdings, Inc. (ESQ) Tops Q2 EPS by 5c
- Union Pacific (UNP) Tops Q2 EPS by 22c
- Albertsons tumbles on earnings miss and slashed guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
